Tag: hormonal contraceptives market analysis

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Hormonal Contraceptives Market Growth Potential: How Will Market Size Shift Through 2030?

The hormonal contraceptives market has observed a slight increase in its size in recent years. This market is set to expand from $14.4 billion in 2025 to $14.58 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 1.2%. Historically, this growth has been driven by increased awareness of family planning, the introduction of combined oral contraceptives, government programs supporting reproductive health, growing urbanization, and the expansion of gynecology clinics.

The hormonal contraceptives market is anticipated to show steady expansion in the upcoming period, with its size projected to reach $15.82 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 2.1%. This expected growth can be attributed to advancements in personalized hormone therapies, the introduction of male contraceptive products, the broadening of e-commerce platforms for contraceptives, the integration of digital health solutions, and a growing emphasis on preventing sexually transmitted diseases. Significant trends during this forecast period include the rise of individualized hormone-based contraceptives, increased awareness of reversible and non-reversible birth control methods, the expansion of telemedicine and online contraceptive services, the development of male contraceptive options, and a focus on contraceptives that offer dual protection against STDs.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=54938558&type=smp&name=Hormonal%20Contraceptives%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Hormonal Contraceptives Market Growth Factors: What’s Supporting Expansion?

The increasing public understanding of hormonal contraceptives has led to a more informed and empowered populace, enabling individuals to select options that align with their reproductive objectives and lifestyles. As people gain greater knowledge about contraceptive choices, they are better equipped to make decisions about their reproductive health, which, in turn, boosts the adoption of hormonal contraceptives that suit their family planning and lifestyle preferences. For instance, in July 2025, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations focusing on international public health, indicated that 874 million women now use modern contraceptives. This access to family planning enhances public health, promotes gender equality, strengthens health systems, and fosters economic development, with an additional 70 million women anticipated to gain access by 2030. Therefore, heightened awareness regarding the benefits and application of contraceptives significantly drives the hormonal contraceptives market. The rising healthcare expenditure is projected to fuel the expansion of the hormonal contraceptives market. Healthcare expenditure refers to the overall financial resources allocated by individuals, organizations, or governments for the prevention, treatment, and management of health conditions. This spending is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often carry higher costs, leading to greater overall healthcare spending. Increased healthcare expenditure promotes the use of hormonal contraceptives by improving access, affordability, awareness, and by supporting research and development as well as family planning initiatives. For example, in December 2024, the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering Medicare and Medicaid programs, reported that in 2023, U.S. health care expenditures rose by 7.5%, reaching $4.9 trillion, which is approximately $14,570 per individual. Consequently, the growing healthcare expenditure is propelling the growth of the hormonal contraceptives market.

Hormonal Contraceptives Market Segment Analysis Spotlighting Growth Areas

The hormonal contraceptives market covered in this report is segmented –

1) By Product: Pills, Injectable Birth Control, Vaginal Rings, Others

2) By End User: Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers

3) By Hormones: Progestin-Only, Combined Hormones

4) By Distribution Channel: Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels

Subsegments:

1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills

2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants

3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings

4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

Hormonal Contraceptives Market Industry Trends: What’s Reshaping Demand?

Leading companies within the hormonal contraceptives market are developing advanced products, such as nonprescription daily oral contraceptives, to improve accessibility and convenience for users. This type of birth control pill can be purchased without a prescription from a healthcare provider. For instance, in July 2023, Perrigo Company PLC, a US-based manufacturer of private label over-the-counter pharmaceuticals, secured approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting the public health, for Opill. Opill is the first nonprescription daily oral contraceptive, which will be available to consumers without a prescription. The introduction of Opill marks a pivotal moment in reproductive health, as it allows individuals to access effective birth control without the barriers of needing a prescription or a healthcare appointment.

Hormonal Contraceptives Market Leading Companies: Who Holds The Strongest Market Presence?

Major companies operating in the hormonal contraceptives market are Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy Care, Mylan Laboratories

View The Full Hormonal Contraceptives Market Report:

https://thebusinessresearchcompany.com/report/Hormonal-Contraceptives-Global-Market-Report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Hormonal Contraceptives Market Regional Analysis: Which Geography Leads On Revenue?

North America was the largest region in the hormonal contraceptives market share in 2025. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Hormonal Contraceptives Market Expansion From $14.57 Billion In 2026 To $15.82 Billion In 2030

The market for hormonal contraceptives experienced slight expansion in recent times, with its valuation increasing from $14.4 billion in 2025 to $14.58 billion in 2026, reflecting a compound annual growth rate (CAGR) of 1.2%. This historical growth was fueled by greater awareness regarding family planning, the launch of combined oral contraceptives, government-led reproductive health programs, higher levels of urbanization, and a rising number of gynecology clinics.

The size of the hormonal contraceptives market is anticipated to experience consistent expansion over the coming years, ultimately reaching $15.82 billion by 2030, reflecting a compound annual growth rate (CAGR) of 2.1%. This projected growth during the forecast period is driven by factors such as progress in tailoring hormone therapies to individuals, the emergence of contraceptive products for men, the growing reach of online sales channels for contraceptives, the incorporation of digital health tools, and a heightened emphasis on preventing sexually transmitted diseases. Key developments expected in this timeframe encompass the growing adoption of personalized, hormone-based birth control methods, heightened awareness among consumers regarding both reversible and permanent options, the expansion of telehealth services and online contraceptive access, the rollout of new male birth control alternatives, and a stronger emphasis on contraceptives that offer dual protection against STDs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Hormonal Contraceptives Market Growth Momentum: Which Factors Are Influencing Demand?

Growing knowledge about hormonal contraceptives has fostered a more informed and empowered population, enabling individuals to select options that fit their reproductive aspirations and way of life. With greater understanding of contraceptive choices, people are more capable of making improved decisions regarding their reproductive health, which subsequently boosts the uptake of hormonal contraceptives that suit their family planning needs and lifestyle preferences. For example, in July 2025, the World Health Organization (WHO), a Switzerland-based UN agency specializing in international public health, reported that 874 million women are currently using modern contraceptives, and access to family planning bolsters public health, advances gender equality, strengthens health systems, and fosters economic development. A further 70 million women are expected to gain access by 2030. Heightened awareness of contraceptive benefits and usage significantly drives the hormonal contraceptives market forward.

Healthcare spending is on the rise, and this is anticipated to fuel expansion in the hormonal contraceptives market going forward. Healthcare expenditure encompasses the total financial resources allocated by individuals, organizations, or governments to prevent, treat, and manage health conditions. It is growing due to progress in medical technology, as new diagnostic instruments, treatments, and innovative therapies often come with higher costs, leading to increased overall spending in the sector. This increase promotes the use of hormonal contraceptives by enhancing access, affordability, awareness, and by supporting research and development along with family planning initiatives. As an illustration, in December 2024, the Centers for Medicare & Medicaid Services, a US agency that oversees Medicare and Medicaid programs, noted that in 2023, U.S. healthcare spending rose by 7.5%, reaching $4.9 trillion, roughly $14,570 per person. Consequently, the rising healthcare expenditure is propelling growth in the hormonal contraceptives market.

Hormonal Contraceptives Market Segmentation Trends And Revenue Drivers

The hormonal contraceptives market covered in this report is segmented –

1) By Product: Pills, Injectable Birth Control, Vaginal Rings, Others

2) By End User: Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers

3) By Hormones: Progestin-Only, Combined Hormones

4) By Distribution Channel: Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels

Subsegments:

1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills

2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants

3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings

4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

Hormonal Contraceptives Market Trends Reshaping Industry Growth

Key players in the hormonal contraceptives sector are developing groundbreaking items, including over-the-counter daily oral birth control pills, aimed at improving user access and simplicity. An over-the-counter daily oral contraceptive refers to a birth control pill accessible for purchase without requiring a prescription from a medical professional. As an example, in July 2023, Perrigo Company PLC, a U.S.-based producer of private-label nonprescription pharmaceuticals, secured clearance from the Food and Drug Administration (FDA), a U.S. federal agency dedicated to safeguarding public health, for its product Opill. Opill represents the first daily oral contraceptive available without a prescription, becoming obtainable for consumers without needing a doctor’s order. The launch of Opill signifies a critical milestone in reproductive healthcare, enabling individuals to obtain reliable contraception free from the obstacles associated with securing a prescription or scheduling a medical visit.

Hormonal Contraceptives Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the hormonal contraceptives market are Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy Care, Mylan Laboratories

Access The Complete Hormonal Contraceptives Market Report:

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Hormonal Contraceptives Market Regional Analysis And Leading Geography

North America was the largest region in the hormonal contraceptives market share in 2025. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Hormonal Contraceptives Market During The 2026–2030 Period?

Recent years have witnessed a modest increase in the size of the hormonal contraceptives market. This market is projected to expand from $14.4 billion in 2025 to $14.58 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 1.2%. Historically, this growth was influenced by heightened awareness regarding family planning, the introduction of combined oral contraceptives, governmental programs for reproductive well-being, increased urban development, and the expansion of gynecology clinics.

The hormonal contraceptives market size is anticipated to experience consistent expansion over the coming years. Its value is predicted to reach $15.82 billion in 2030, showing a compound annual growth rate (CAGR) of 2.1%. This expansion during the forecast period can be linked to progress in personalized hormone therapies, the emergence of male contraceptive products, the broadening of e-commerce platforms for contraceptives, the incorporation of digital health services, and a greater emphasis on preventing STDs. Significant trends expected during this period include the development of personalized hormone-based contraceptives, increased understanding of both reversible and non-reversible birth control methods, an increase in telemedicine and online contraceptive services, the growth of male contraceptive solutions, and a focus on contraceptives that offer dual protection against STDs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp

Which Major Factors Are Contributing To The Development Of The Hormonal Contraceptives Market?

Enhanced awareness regarding hormonal contraceptives has led to a more knowledgeable and capable populace, enabling individuals to select options that align with their reproductive aspirations and lifestyles. As people become better informed about their contraceptive choices, they are empowered to make improved decisions about their reproductive health, which in turn boosts the adoption of hormonal contraceptives that fit their family planning and lifestyle preferences. For instance, in July 2025, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, indicated that 874 million women now utilize modern contraceptives, demonstrating how access to family planning supports public health, advances gender equality, strengthens health systems, and promotes economic development. An additional 70 million women are projected to gain access by 2030. This elevated understanding of contraceptive benefits and usage significantly propels the hormonal contraceptives market.

How Is The Hormonal Contraceptives Market Distributed Across Key Segments?

The hormonal contraceptives market covered in this report is segmented –

1) By Product: Pills, Injectable Birth Control, Vaginal Rings, Others

2) By End User: Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers

3) By Hormones: Progestin-Only, Combined Hormones

4) By Distribution Channel: Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels

Subsegments:

1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills

2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants

3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings

4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

Which Trends Are Affecting The Hormonal Contraceptives Market Framework?

Major companies in the hormonal contraceptives market are innovating advanced products, such as nonprescription daily oral contraceptives, to enhance user accessibility and convenience. This form of birth control pill can be purchased without a prescription from a healthcare provider. For instance, in July 2023, Perrigo Company PLC, a US-based manufacturer of private label over-the-counter pharmaceuticals, received approval from the Food and Drug Administration (FDA), a US federal agency focused on protecting public health, for Opill. Opill is the first nonprescription daily oral contraceptive, designed to be available to consumers without a prescription. The introduction of Opill signifies a pivotal moment in reproductive health, allowing individuals to access effective birth control without the barriers of needing a prescription or a healthcare appointment.

Who Are The Major Companies Operating In The Hormonal Contraceptives Market?

Major companies operating in the hormonal contraceptives market are Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy Care, Mylan Laboratories

Access The Complete Hormonal Contraceptives Market Report:

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Which Region Accounts For The Highest Share Of The Hormonal Contraceptives Market?

North America was the largest region in the hormonal contraceptives market share in 2025. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Hormonal Contraceptives Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp

Browse Through More Reports Similar to the Global Hormonal Contraceptives Market 2026, By The Business Research Company

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Hormonal Contraceptives Market Grow Between 2026 And 2030?

The hormonal contraceptives market has experienced modest growth in recent years. Its size is expected to expand from $14.4 billion in 2025 to $14.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 1.2%. This historical growth can be linked to factors like increasing awareness of family planning, the development of combined oral contraceptives, government programs for reproductive health, rising urbanization, and an increase in gynecology clinics.

The hormonal contraceptives market size is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $15.82 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 2.1%. The forecasted growth is largely attributable to progress in personalized hormone therapies, the emergence of male contraceptive products, the broadening reach of e-commerce for contraceptives, the integration of digital health platforms, and a heightened emphasis on preventing sexually transmitted diseases. Significant trends identified for this period encompass the development of personalized hormone-based contraceptives, greater public understanding of both reversible and non-reversible contraceptive choices, the increase in telemedicine and virtual contraceptive services, the broadening availability of male contraceptive solutions, and an emphasis on contraceptives offering dual protection against STDs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp

What Key Factors Are Affecting The Hormonal Contraceptives Market Demand?

Enhanced public understanding of hormonal contraceptives has led to a more knowledgeable and empowered populace, enabling individuals to select options that align with their reproductive objectives and lifestyles. As people become better informed about available contraceptive methods, they are better equipped to make decisions regarding their reproductive well-being, which in turn boosts the adoption of hormonal contraceptives that suit their family planning and personal preferences. For instance, in July 2025, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, reported that with 874 million women now using modern contraceptives, ensuring access to family planning supports public health, advances gender equality, strengthens health systems, and fosters economic development. It is projected that an additional 70 million women will gain access by 2030. This heightened awareness regarding the benefits and application of contraceptives significantly propels the Hormonal Contraceptives Market.

How Is The Hormonal Contraceptives Market Organized By Segment Classification?

The hormonal contraceptives market covered in this report is segmented –

1) By Product: Pills, Injectable Birth Control, Vaginal Rings, Others

2) By End User: Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers

3) By Hormones: Progestin-Only, Combined Hormones

4) By Distribution Channel: Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels

Subsegments:

1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills

2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants

3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings

4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

What Trends Are Affecting The Direction Of The Hormonal Contraceptives Market?

Leading companies in the hormonal contraceptives market are innovating advanced products, such as nonprescription daily oral contraceptives, to enhance user accessibility and convenience. A nonprescription daily oral contraceptive is a type of birth control pill that can be purchased without needing a prescription from a healthcare provider. For instance, in July 2023, Perrigo Company PLC, a US-based manufacturer of private label over-the-counter pharmaceuticals, received approval from the Food and Drug Administration (FDA), a US-based federal agency tasked with protecting public health, for Opill. Opill is recognized as the first nonprescription daily oral contraceptive and will be made available to consumers without a prescription. The introduction of Opill marks a pivotal moment for reproductive health, enabling individuals to access effective birth control by removing the barriers associated with requiring a prescription or a healthcare appointment.

Who Are The Industry Participants Involved In The Hormonal Contraceptives Market?

Major companies operating in the hormonal contraceptives market are Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy Care, Mylan Laboratories

Get The Full Hormonal Contraceptives Market Report:

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Which Region Leads The Hormonal Contraceptives Market In Overall Market Size?

North America was the largest region in the hormonal contraceptives market share in 2025. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hormonal Contraceptives Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Browse Through More Reports Similar to the Global Hormonal Contraceptives Market 2026, By The Business Research Company

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Hormonal Contraceptives Market From 2026 To 2030?

The market for hormonal contraceptives has experienced slight growth in its size over recent years. It is projected to expand from $14.4 billion in 2025 to $14.58 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 1.2%. The growth observed in the past can be ascribed to several factors: rising awareness of family planning, the introduction of combined oral contraceptives, government initiatives for reproductive health, increasing urbanization, and the growth of gynecology clinics.

The hormonal contraceptives market size is anticipated to experience consistent growth in the coming years. It is projected to reach $15.82 billion by 2030, driven by a compound annual growth rate (CAGR) of 2.1%. This expansion during the forecast period is attributable to advancements in personalized hormone therapies, the emergence of male contraceptive products, the widening scope of e-commerce for contraceptives, the incorporation of digital health platforms, and an increasing emphasis on STD prevention. Key trends expected over the forecast period include the rise of hormone-based personalized contraceptives, growing awareness of both reversible and non-reversible options, the expansion of telemedicine and online contraceptive services, the development of male contraceptive solutions, and a focus on contraceptives offering dual protection against STDs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp

What Major Drivers Are Influencing Demand In The Hormonal Contraceptives Market?

Enhanced understanding of hormonal contraceptives has cultivated a more knowledgeable and self-reliant populace, enabling individuals to make decisions consonant with their reproductive aspirations and chosen ways of life. A growing grasp of contraceptive alternatives empowers individuals to make improved choices about their reproductive well-being, consequently boosting the uptake of hormonal contraceptives that suit their family planning and lifestyle needs. For instance, in July 2025, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, stated that with 874 million women now using modern contraceptives, access to family planning supports public health, advances gender equality, strengthens health systems, and promotes economic development. An additional 70 million women are projected to gain access by 2030. This heightened appreciation for the advantages and utilization of contraceptives significantly drives forward the hormonal contraceptives market.

Which Segments Are Included In The Analysis Of The Hormonal Contraceptives Market?

The hormonal contraceptives market covered in this report is segmented –

1) By Product: Pills, Injectable Birth Control, Vaginal Rings, Others

2) By End User: Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers

3) By Hormones: Progestin-Only, Combined Hormones

4) By Distribution Channel: Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels

Subsegments:

1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills

2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants

3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings

4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

Which Trends Are Impacting The Growth Of The Hormonal Contraceptives Market?

Major companies in the hormonal contraceptives market are innovating advanced products, such as nonprescription daily oral contraceptives, to improve user accessibility and convenience. This type of birth control pill can be purchased without a prescription from a healthcare provider. For instance, in July 2023, Perrigo Company PLC, a US-based manufacturer of private label over-the-counter pharmaceuticals, received approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting public health, for Opill. Opill is recognized as the first nonprescription daily oral contraceptive, designed to be available to consumers without a prescription. The introduction of Opill represents a pivotal moment in reproductive health, as it enables individuals to access effective birth control without the barriers of needing a prescription or a healthcare appointment.

Which Key Industry Participants Are Active In The Hormonal Contraceptives Market?

Major companies operating in the hormonal contraceptives market are Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy Care, Mylan Laboratories

Read the full hormonal contraceptives market report here:

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Hormonal Contraceptives Market?

North America was the largest region in the hormonal contraceptives market share in 2025. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hormonal Contraceptives Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2440&type=smp

Browse Through More Reports Similar to the Global Hormonal Contraceptives Market 2026, By The Business Research Company

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the hormonal contraceptives market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Hormonal Contraceptives Market show for the 2026–2030 period?

The market size for hormonal contraceptives has experienced marginal growth in recent years. It is anticipated to expand from $14.4 billion in 2025 to $14.58 billion in 2026, at a compound annual growth rate (CAGR) of 1.2%. This historical growth can be ascribed to several factors, including heightened awareness of family planning, the introduction of combined oral contraceptives, government initiatives promoting reproductive health, increasing urbanization, and the rise of gynecology clinics.

The hormonal contraceptives market size is anticipated to experience consistent growth over the coming years. It is projected to expand to $15.82 billion in 2030, achieving a compound annual growth rate (CAGR) of 2.1%. This expansion during the forecast period is attributable to advancements in personalized hormone therapies, the emergence of male contraceptive products, the broadening of e-commerce for contraceptives, the integration of digital health platforms, and a heightened focus on STD prevention. Significant trends expected in the forecast period involve the rise of hormone-based personalized contraceptives, increasing awareness of reversible and non-reversible options, growth in telemedicine and online contraceptive services, the expansion of male contraceptive solutions, and an emphasis on contraceptives offering dual protection against STDs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp

What Drivers Are Shaping The Development Of The Hormonal Contraceptives Market?

Enhanced understanding of hormonal contraceptives has fostered a more knowledgeable and empowered population, allowing individuals to make choices that align with their reproductive goals and lifestyles. As people become more informed about contraceptive options, they are better equipped to make decisions regarding their reproductive health, which in turn leads to greater adoption of hormonal contraceptives that align with their family planning and lifestyle preferences. For instance, in July 2025, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, with 874 million women now using modern contraceptives, access to family planning supports public health, advances gender equality, strengthens health systems, and promotes economic development. An additional 70 million women are projected to gain access by 2030. Elevated awareness regarding the advantages and utilization of contraceptives significantly propels the Hormonal Contraceptives Market.

What Segment Types Are Examined In The Hormonal Contraceptives Market?

The hormonal contraceptives market covered in this report is segmented –

1) By Product: Pills, Injectable Birth Control, Vaginal Rings, Others

2) By End User: Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers

3) By Hormones: Progestin-Only, Combined Hormones

4) By Distribution Channel: Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels

Subsegments:

1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills

2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants

3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings

4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

Which Trends Are Guiding The Evolution Of The Hormonal Contraceptives Market?

Major companies within the hormonal contraceptives market are innovating advanced products, such as nonprescription daily oral contraceptives, to enhance user accessibility and convenience. A nonprescription daily oral contraceptive refers to a type of birth control pill that can be purchased without needing a prescription from a healthcare provider. For instance, in July 2023, Perrigo Company PLC, a US-based manufacturer of private label over-the-counter pharmaceuticals, received approval from the Food and Drug Administration (FDA), a US-based federal agency tasked with protecting public health, for Opill. Opill is distinguished as the first nonprescription daily oral contraceptive, which will be made available to consumers without a prescription. The introduction of Opill marks a pivotal moment in reproductive health, as it allows individuals to access effective birth control by removing the barriers of requiring a prescription or a healthcare appointment.

Who Are The Major Companies Operating In The Hormonal Contraceptives Market?

Major companies operating in the hormonal contraceptives market are Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy Care, Mylan Laboratories

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Hormonal Contraceptives Market?

North America was the largest region in the hormonal contraceptives market share in 2025. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hormonal Contraceptives Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2440&type=smp

Browse Through More Reports Similar to the Global Hormonal Contraceptives Market 2026, By The Business Research Company

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the hormonal contraceptives market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Hormonal Contraceptives Market Be Worth By 2029, And What CAGR Will It Achieve?

The hormonal contraceptives market size has experienced a modest increase in recent years. It is anticipated to expand from $14.28 billion in 2024 to $14.4 billion in 2025, reflecting a compound annual growth rate (CAGR) of 0.9%. The historical growth witnessed in this period can be ascribed to several factors, including government initiatives, a rise in the adoption of contraceptives, an uptick in pharmaceutical research and development expenditure, elevated healthcare spending, and an expansion in the number of healthcare facilities.

The hormonal contraceptives market size is anticipated to experience modest expansion in the coming years. It is projected to achieve a value of $15.46 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 1.8%. This projected growth during the forecast period is driven by factors such as increasing awareness about family planning, augmented spending on research and development, a rise in healthcare expenditure, and strengthening collaborations between various agencies. Key trends expected in the forecast period include ongoing investments in longer-lasting vaginal rings, utilizing AI solutions to enhance medication adherence, launching new innovative products, focusing on an environmentally friendly estrogen profile, developing improved progestogen-only birth control pills, and continued investment in long-term drug delivery systems.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp

Which Factors Are Driving The Hormonal Contraceptives Market Forward?

Increased understanding of hormonal contraceptives has fostered a more informed and empowered population, allowing individuals to make choices that align with their reproductive goals and lifestyles. As people become more knowledgeable about contraceptive options, they are better equipped to make decisions regarding their reproductive health, which in turn boosts the adoption of hormonal contraceptives suitable for their family planning and lifestyle preferences. For instance, in September 2023, as per the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, in 2022, the estimated global prevalence of contraception, including any method, was 65%, while the prevalence of modern contraceptive methods was reported at 58.7% among married women in a union. The global satisfaction rate for the use of modern family planning methods among women aged 15–49 will be 77.5% in 2022. Enhanced awareness concerning the benefits and application of contraceptives significantly propels the hormonal contraceptives market.

Which Segments Form The Key Structure Of The Hormonal Contraceptives Market?

The hormonal contraceptives market covered in this report is segmented –

1) By Product : Pills, Injectable Birth Control, Vaginal Rings, Others

2) By End User : Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers

3) By Hormones : Progestin-Only, Combined Hormones

4) By Distribution Channel : Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels

Subsegments:

1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills

2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants

3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings

4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

What Strategic Shifts And Innovations Are Influencing The Hormonal Contraceptives Market?

Firms are developing chewable, low-dose oral contraceptives intended to minimize side effects and streamline daily usage for patients. This contraceptive is already available for purchase over-the-counter. Leading companies that manufacture and distribute chewable low-dose oral contraceptives include Lupin Pharmaceuticals, Walter Chilcott, and Watson Pharmaceuticals.

Which Firms Are Making The Biggest Impact In The Hormonal Contraceptives Market?

Major companies operating in the hormonal contraceptives market include Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy care, Mylan Laboratories

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Which Region Is Expected To Lead The Hormonal Contraceptives Market In The Next Few Years?

North America was the largest region in the hormonal contraceptives market share in 2024. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2440&type=smp

Browse Through More Reports Similar to the Global Hormonal Contraceptives Market 2025, By The Business Research Company

Therapeutic Proteins Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Injectable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Hormonal Contraceptives Market Over The Five-Year Period 2025–2029?

The hormonal contraceptives market size has demonstrated slight growth in recent years. It is projected to expand from $14.28 billion in 2024 to $14.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 0.9%. This historical growth can be attributed to several factors, including government initiatives, a rise in contraceptive usage, increased expenditure on pharmaceutical research and development, higher healthcare spending, and an expansion in the number of healthcare facilities.

The hormonal contraceptives market size is projected to experience modest growth over the next few years. It is expected to expand to $15.46 billion in 2029, achieving a compound annual growth rate (CAGR) of 1.8%. This anticipated growth during the forecast period stems from factors such as increasing awareness surrounding family planning, higher spending on research and development, a rise in general healthcare expenditure, and enhanced collaborations between various agencies. Significant trends identified for the forecast period include investments in longer-lasting vaginal rings, the adoption of AI solutions to improve medication adherence, the introduction of new innovative products, a focus on environmentally friendly estrogen profiles, the development of improved progestogen-only birth control pills, and continued investment in long-term drug delivery systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Hormonal Contraceptives Industry?

Increased knowledge about hormonal contraceptives has fostered a more informed and self-reliant population, allowing individuals to make choices that align with their reproductive aspirations and lifestyles. As people gain greater insight into contraceptive options, they are better equipped to make decisions regarding their reproductive health, which, in turn, encourages a higher adoption rate of hormonal contraceptives that suit their family planning and lifestyle preferences. For instance, in September 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations focused on international public health, in 2022, the estimated global prevalence of contraception, encompassing all methods, was 65%, while the prevalence of modern contraceptive methods among married women in a union was reported at 58.7%. The global satisfaction rate for modern family planning methods among women aged 15–49 stood at 77.5% in 2022. This elevated awareness regarding the advantages and proper use of contraceptives significantly propels the hormonal contraceptives market.

Which Key Segments Fueling The Hormonal Contraceptives Market?

The hormonal contraceptives market covered in this report is segmented –

1) By Product : Pills, Injectable Birth Control, Vaginal Rings, Others

2) By End User : Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers

3) By Hormones : Progestin-Only, Combined Hormones

4) By Distribution Channel : Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels

Subsegments:

1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills

2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants

3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings

4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

What Key Innovation Trends Are Fueling Advancements In The Hormonal Contraceptives Market?

Businesses are innovating to produce chewable, low-dose oral contraceptives aimed at mitigating side effects. This initiative for chewable contraceptives seeks to diminish adverse reactions while simultaneously facilitating patient adherence to a daily regimen for this birth control method. The pill is currently available for purchase as an over-the-counter product. Among the prominent companies that manufacture and distribute chewable low-dose oral contraceptives are Lupin Pharmaceuticals, Walter Chilcott, and Watson Pharmaceuticals.

Which Key Market Players Are Investing In Expansion And Innovation Of Hormonal Contraceptives Market?

Major companies operating in the hormonal contraceptives market include Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy care, Mylan Laboratories

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Which Region Is Projected To Lead The Hormonal Contraceptives Market During The Forecast Period?

North America was the largest region in the hormonal contraceptives market share in 2024. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Hormonal Contraceptives Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2440&type=smp

Browse Through More Reports Similar to the Global Hormonal Contraceptives Market 2025, By The Business Research Company

Therapeutic Proteins Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Injectable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Projected Valuation Of The Hormonal Contraceptives Market In The Coming Years?

In recent times, there has been a slight increase in the market size of hormonal contraceptives. The market, which stands at $14.28 billion in 2024, is projected to increase to $14.4 billion in 2025, reflecting a compound annual growth rate (CAGR) of 0.9%. This growth during the historical period is the result of several factors, including government initiatives, the escalating use of contraceptives, a surge in pharmaceutical research and development spending, an increase in healthcare expenditure, and a rise in the number of healthcare facilities available.

Expectations are set for a slight increase in the size of the hormonal contraceptives market over the next few years, reaching a value of $15.46 billion in 2029 with a compound annual growth rate (CAGR) of 1.8%. The expected growth can be attributed to the rise in consciousness about family planning, increase in spendings on research and development, surge in healthcare expenditure, and growing partnerships between different agencies within the forecast period. The trending factors contributing to this growth are the investments made in long-lasting vaginal rings, incorporation of AI to enhance medication adherence, launching innovative goods in the market, focusing on eco-friendly estrogen profiles, improved progestogen only birth control pills, and the continued investment in extended drug delivery systems.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp

Which Industry Forces Are Driving The Hormonal Contraceptives Market Forward?

The rise in understanding of hormonal contraceptives has led to a population that is better informed and empowered, enabling them to make decisions that align with their reproductive ambitions and personal lifestyles. People who are well-informed about the various options of contraception are better positioned to make effective decisions about their reproductive wellbeing, leading to a surge in adoption of hormonal contraceptives that are in alignment with their family planning needs and lifestyle choices. For example, in September 2023, the World Health Organization (WHO), a Switzerland-based branch of the United Nations that oversees global public health, reported that in 2022, the estimated worldwide prevalence of all types of contraception was 65%, and the usage of modern contraceptive methods was 58.7% among married women in unions. The worldwide satisfaction level with modern family planning methods among women ages 15-49 in 2022 is anticipated to reach 77.5%. This heightened consciousness about the benefits and use of contraceptives is a major driving force for the hormonal contraceptives market.

How Does The Hormonal Contraceptives Market Differ By Segment?

The hormonal contraceptives market covered in this report is segmented –

1) By Product : Pills, Injectable Birth Control, Vaginal Rings, Others

2) By End User : Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers

3) By Hormones : Progestin-Only, Combined Hormones

4) By Distribution Channel : Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels

Subsegments:

1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills

2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants

3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings

4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

What New Opportunities Are Emerging From Trends In The Hormonal Contraceptives Market?

Firms are pioneering the creation of chewable, low-dose oral birth control pills to reduce adverse effects. The development of the chewable contraceptives was an effort to minimize the side effects while simultaneously simplifying the daily consumption routine for users. The contraceptive pill has already made its way to the over-the-counter market. Lupin Pharmaceuticals, Walter Chilcott, and Watson Pharmaceuticals are among the leading companies that manufacture and market these chewable, low dose contraceptives.

Which Firms Are Making The Biggest Impact In The Hormonal Contraceptives Market?

Major companies operating in the hormonal contraceptives market include Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy care, Mylan Laboratories

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Which Region Is Leading Innovation In The Hormonal Contraceptives Market?

North America was the largest region in the hormonal contraceptives market share in 2024. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2440&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Hormonal Contraceptives Market Through 2029?

Recently, there has been a slight expansion in the market size of hormonal contraceptives. This market is projected to rise from $14.28 billion in 2024 to $14.4 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 0.9%. The historic growth can be traced back to factors such as government initiatives, the widened usage of contraceptives, an increase in the expenditure on pharmaceutical research and development, a surge in healthcare spending, and a rise in the number of healthcare facilities.

In the coming years, the market size of hormonal contraceptives is projected to experience a slight expansion. The market is forecasted to reach “$15.46 billion in 2029, growing at a compound annual growth rate (CAGR) of 1.8%. Factors contributing to this growth during the forecast period include an increase in family planning awareness, an upsurge in research and development expenditure, a rise in healthcare spending, and augmenting partnerships between agencies. The forecast period is expected to observe trends such as investment in durable vaginal rings, adoption of AI to enhance medication compliance, the introduction of innovative products, focus on environmentally friendly estrogen profile, improvement in progestogen-only birth control pills, and continuing investment in long-lasting delivery drug systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp

What Market Forces Are Driving The Hormonal Contraceptives Sector In 2025 And Beyond?

The heightened understanding of hormonal contraceptives is enhancing the knowledge and autonomy of the global populace, enabling them to make suitable reproductive and lifestyle decisions. This expanding knowledge on contraceptive options empowers individuals to make smarter choices concerning their reproductive well-being, which consequently leads to greater use of hormonal contraceptives that match their family planning needs and lifestyle choices. For example, the World Health Organization (WHO), a Switzerland-based UN agency focusing on global public health, revealed in September 2023 that the estimated worldwide use of any contraceptive method was 65% in 2022, and the use of modern contraceptive methods among married or partnered women stood at 58.7%. The satisfaction rate across the globe for employing modern family planning methods among women between 15–49 years is predicted to reach 77.5% in 2022. The increased consciousness about the benefits and proper use of contraceptives considerably fuels the hormonal contraceptives market.

The hormonal contraceptives market covered in this report is segmented –

1) By Product : Pills, Injectable Birth Control, Vaginal Rings, Others

2) By End User : Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers

3) By Hormones : Progestin-Only, Combined Hormones

4) By Distribution Channel : Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels

Subsegments:

1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills

2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants

3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings

4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men

What Long-Term Trends Are Likely To Affect The Hormonal Contraceptives Market?

Firms are pioneering the development of masticable, low-dose oral birth control to minimize side effects. This chewable contraceptive project was a move towards reducing adverse health effects and simultaneously facilitating patients’ assimilation into daily use of the contraceptive. The medicine is currently available for purchase without a prescription. Leading players in the creation and distribution of chewable, low-dose contraceptives are companies such as Lupin Pharmaceuticals, Walter Chilcott, and Watson Pharmaceuticals.

Which Firms Are Considered Leaders In The Hormonal Contraceptives Market Space?

Major companies operating in the hormonal contraceptives market include Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy care, Mylan Laboratories

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

What Role Do Regional Policies And Investments Play In Hormonal Contraceptives Market Expansion?

North America was the largest region in the hormonal contraceptives market share in 2024. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2440&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model